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Dr JohnA.Kern (Charlottesville, Va). Dr Xydas, I congratulate
you on a nice presentation and study. Looking back at your last
330-odd aortic patients, as you point out, 37 underwent TAAR
procedures with good results. With the advent of endovascular
technology, your group, like many groups, is getting creative in
ways to minimize circulatory arrest times, minimize cerebral
malperfusion times, and improve outcomes, and certainly with
this study and this small group of patients you have done that.
You have certainly demonstrated decreased CPB, crossclamp,
and circulatory arrest times. I really have just a few questions,
some of which are technical. Tell me about the CSB. Did you
always do that concomitantly with the arch procedure, or did you
do that a day or so before? In addition to that, because it appears
that it is routine, because you are using the CSB to maintain carotid
perfusion, did you necessarily image the head to define the cerebro-
vascular anatomy?
Dr Xydas. We do the left CSB in the same setting and start off
our procedure with it in the operating room. The rationale for this is
that potentially if it was done earlier, even over the weekend or
a couple of days, graft patency might be diminished if there was
competitive flow. In terms of the rationale for doing the left CSB,
it is really 2-fold. One reason is in doing the carotid anastomosis
through the sternotomy, it allows us protection with the subcla-
vian–carotid flow during that span. So the anatomy is not necessar-
ily something to which we have to react. We did not do any cerebral
imaging other than the standard preoperative computed tomo-
graphic angiography. The second reason for doing the bypass is
that it eliminates the need for doing the subclavian–graft anastomo-
sis in the chest, which is typically difficult in a deep hole with
imperfect visualization.
Dr Kern. Your mean follow-up time naturally was around
7 months, as you point out, and I imagine most of these patients
are older. Certainly the CSB is the easier operation. This is almost
a complete TAAR, so I really congratulate you on avoiding the arch
debranching procedures, which establish blood flow to the great
vessels through a smaller graft coming off the ascending aorta. I
think the durability of this procedure is going to be quite good;
however, with the CSB over time, you can’t be sure. In the TEVAR722 The Journal of Thoracic and Cardiovascular Surggroup, the second group, you have done the endograft both simul-
taneously and staged in that small group, is that right?
Dr Xydas. Yes, this is correct.
Dr Kern. Do you have any preferences, do you have anything
you can tell us about when you prefer to do it at the same time
versus when you stage it?
Dr Xydas. This issue requires ongoing work, and there are no
clear winners in terms of how to approach this. We did this partly
on clinical grounds but also on administrative grounds in terms of
whether the hybrid room was available for doing the procedure
concomitantly versus in a staged manner. If there was an extensive
concomitant procedure expected, however, we did opt to do it in
a staged approach. Only 2 of 9 patients underwent the procedure
concomitantly, with the other 7 undergoing it in a staged fashion.
Again, however, I think that only future research in this area will
enlighten us as to which approach is going to be better. It was
interesting at this meeting to hear from Dr Griepp’s group, which
presented data suggesting that performing it in a staged fashion
past 5 to 7 days may decrease the incidence of spinal cord ische-
mia or other neurologic issues. In terms of the patency of the left
CSB, once you are in the postoperative phase, our expectation is
that even if the patency rates of these grafts are low, this is not go-
ing to affect the patients neurologically in that many patients un-
dergoing TEVAR actually have their left subclavian artery
occluded and covered with the TEVAR without a bypass and
seem to do relatively well. Staging it enough to allow collaterali-
zation to some degree will probably diminish even further the
effect of left carotid–subclavian graft patency on long-term
neurologic outcome.
Dr Kern. For those couple of patients who underwent concom-
itant stent grafting, did you use a lumbar drain? Did they undergo
extensive enough stent grafting that you used a lumbar drain?
Dr Xydas. The patients who underwent concomitant procedures
had a lumbar drain. Patients who underwent the staged procedure
also had lumbar drains routinely, even if they didn’t require exten-
sive stenting across the descending aorta.
Dr Joseph E. Bavaria (Philadelphia, Pa). Do you coil out your
left subclavian at the end?
Dr Xydas. We do occlude the proximal left subclavian artery at
the end of the procedure. If it is easy to approach through the ster-
notomy, we either staple it or ligate it. If not, we approach it endo-
vascularly at the time of the TEVAR through a staged approach.
Dr Bavaria. Also, you can’t put a large GORE graft through an
8-mm graft. So are you using small grafts? We usually use a 10-mm
side arm.
DrXydas.We are actually using a 9-mm side branch on our cus-
tom aortic grafts for use with concomitant TEVAR procedures with
both small and large stent grafts.
Dr Lars G. Svensson (Cleveland, Ohio). Thank you, Dr Xydas.
This is an interesting field, and maybe some people should get
together and do a multicenter study on this, because there are
a lot of evolving issues here, as you brought up.
Dr Xydas. Thank you.ery c March 2010
